scholarly article | Q13442814 |
P50 | author | Adam Carrico | Q88523191 |
Allan E Rodriguez | Q90102626 | ||
P2093 | author name string | Mario Stevenson | |
Mark Sharkey | |||
Michael H Antoni | |||
Tiffany R Glynn | |||
Jessica Salinas | |||
Olorunleke Oni | |||
Danita Jemison | |||
P2860 | cites work | Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. | Q52572947 |
Novel Latency Reversal Agents for HIV-1 Cure. | Q52816327 | ||
CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. | Q53211334 | ||
Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. | Q53775784 | ||
HIV: Shock and kill. | Q55056512 | ||
Stimulant Use and Viral Suppression In the Era of Universal Antiretroviral Therapy | Q57071235 | ||
PD-1 blockade potentiates HIV latency reversal ex vivo in CD4 T cells from ART-suppressed individuals | Q64252705 | ||
HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study. | Q64921701 | ||
Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine Users | Q90481968 | ||
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs? | Q26822422 | ||
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation | Q29619611 | ||
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder | Q33772700 | ||
A simple single-item rating scale to measure medication adherence: further evidence for convergent validity | Q34462551 | ||
Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy | Q34513996 | ||
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies | Q34607763 | ||
Towards an HIV cure: a global scientific strategy | Q34640562 | ||
Enhanced replication of simian immunodeficiency virus adjacent to catecholaminergic varicosities in primate lymph nodes. | Q34647468 | ||
An internationally generalizable risk index for mortality after one year of antiretroviral therapy. | Q34813110 | ||
HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients | Q34922069 | ||
Cocaine modulates HIV-1 integration in primary CD4+ T cells: implications in HIV-1 pathogenesis in drug-abusing patients | Q35207116 | ||
Addiction motivation reformulated: an affective processing model of negative reinforcement | Q35645919 | ||
Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective Study | Q35736120 | ||
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. | Q35990287 | ||
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis | Q36747893 | ||
Cell-associated HIV RNA: a dynamic biomarker of viral persistence | Q36798408 | ||
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. | Q37104874 | ||
Role of depression, stress, and trauma in HIV disease progression | Q37180015 | ||
Prevalence and correlates of substance use among youth living with HIV in clinical settings. | Q37478571 | ||
Substance use and HIV disease progression in the HAART era: Implications for the primary prevention of HIV | Q37799090 | ||
Psychological trauma and PTSD in HIV-positive women: a meta-analysis | Q37976387 | ||
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure | Q37999624 | ||
HIV therapy-the state of art. | Q38395370 | ||
Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. | Q41118221 | ||
HIV reservoirs as obstacles and opportunities for an HIV cure | Q41216521 | ||
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. | Q41880147 | ||
Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study | Q42054863 | ||
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States | Q43694055 | ||
Relation of lifetime trauma and depressive symptoms to mortality in HIV. | Q44363402 | ||
Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy | Q44692012 | ||
Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals | Q44693769 | ||
Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy | Q46159115 | ||
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale | Q46572937 | ||
Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site | Q46646611 | ||
Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS. | Q46702797 | ||
What do we measure when we measure cell-associated HIV RNA. | Q47548192 | ||
Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection | Q47549005 | ||
Posttraumatic stress disorder and drug disorders: testing causal pathways. | Q50861285 | ||
Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations. | Q51594607 | ||
Cocaine dependence with and without post-traumatic stress disorder: a comparison of substance use, trauma history and psychiatric comorbidity. | Q51975397 | ||
P433 | issue | 5 | |
P921 | main subject | post-traumatic stress disorder | Q202387 |
P304 | page(s) | 542-550 | |
P577 | publication date | 2019-10-01 | |
P1433 | published in | International Journal of Behavioral Medicine | Q15752478 |
P1476 | title | Post-traumatic Stress Disorder, Cocaine Use, and HIV Persistence | |
P478 | volume | 26 |
Search more.